{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:00:56Z","timestamp":1790744456413,"version":"4.1.0"},"reference-count":27,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,10,15]]},"DOI":"10.1248\/bpb.b25-00309","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T22:10:11Z","timestamp":1760479811000},"page":"1540-1546","source":"Crossref","is-referenced-by-count":2,"title":["Effect of Benzo[a]pyrene on Cellular Senescence in MCF7 Breast Cancer Cells"],"prefix":"10.1248","volume":"48","author":[{"given":"Natsuko","family":"Kitamoto","sequence":"first","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Haga","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan"},{"name":"School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Tsujii","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minami","family":"Kubo","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Higashisaka","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan"},{"name":"School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan"},{"name":"Institute for Advanced Co-Creation Studies, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Tsutsumi","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan"},{"name":"School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan"},{"name":"Graduate School of Medicine, The University of Osaka, 2\u20132 Yamadaoka, Suita, Osaka 565\u20130871, Japan"},{"name":"Global Center for Medical Engineering and Informatics, The University of Osaka, 2\u20132 Yamadaoka, Suita, Osaka 565\u20130871, Japan"},{"name":"Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka, 1\u20131 Yamadaoka, Suita, Osaka 565\u20130871, Japan"},{"name":"R3 Institute for Newly-Emerging Science Design, The University of Osaka, 1\u20133 Machikaneyama-cho, Toyonaka, Osaka 560\u20138531, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Iwasaki M, Itoh H, Sawada N, Tsugane S. Exposure to environmental chemicals and cancer risk: epidemiological evidence from Japanese studies. <i>Genes Environ<\/i>, <b>45<\/b>, 10 (2023).","DOI":"10.1186\/s41021-023-00268-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Ghosh  R, Rojanasakul  Y. Evaluating Carcinogenic Potential of Carbon Nanomaterials. <i>Nanotechnology Characterization Tools for Environment, Health, and Safety<\/i>. (Kumar CSSR ed.) Springer Berlin Heidelberg, Berlin, Heidelberg, pp. 103\u2013144 (2019).","DOI":"10.1007\/978-3-662-59600-5_4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Menzie CA, Potocki BB, Santodonato J. Exposure to carcinogenic PAHs in the environment. <i>Environ. Sci. Technol.<\/i>, <b>26<\/b>, 1278\u20131284 (1992).","DOI":"10.1021\/es00031a002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Zaorsky NG, Churilla TM, Egleston BL, Fisher SG, Ridge JA, Horwitz EM, Meyer JE. Causes of death among cancer patients. <i>Ann. Oncol.<\/i>, <b>28<\/b>, 400\u2013407 (2017).","DOI":"10.1093\/annonc\/mdw604"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Huang W, Hickson LJ, Eirin A, Kirkland JL, Lerman LO. Cellular senescence: the good, the bad and the unknown. <i>Nat. Rev. Nephrol.<\/i>, <b>18<\/b>, 611\u2013627 (2022).","DOI":"10.1038\/s41581-022-00601-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Schmitt CA, Wang B, Demaria M. Senescence and cancer\u2014role and therapeutic opportunities. <i>Nat. Rev. Clin. Oncol.<\/i>, <b>19<\/b>, 619\u2013636 (2022).","DOI":"10.1038\/s41571-022-00668-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Milanovic M, Fan DNY, Belenki D, <i>et al<\/i>. Senescence-associated reprogramming promotes cancer stemness. <i>Nature<\/i>, <b>553<\/b>, 96\u2013100 (2018).","DOI":"10.1038\/nature25167"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kim YH, Choi YW, Lee J, Soh EY, Kim JH, Park TJ. Senescent tumor cells lead the collective invasion in thyroid cancer. <i>Nat. Commun.<\/i>, <b>8<\/b>, 15208 (2017).","DOI":"10.1038\/ncomms15208"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Cogliano VJ, Baan RA, Straif K, Grosse Y, Secretan MB, El Ghissassi F, Kleihues P. The Science and practice of carcinogen identification and evaluation. <i>Environ. Health Perspect.<\/i>, <b>112<\/b>, 1269\u20131274 (2004).","DOI":"10.1289\/ehp.6950"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Di Micco R, Krizhanovsky V, Baker D, d\u2019Adda Di Fagagna F. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. <i>Nat. Rev. Mol. Cell Biol.<\/i>, <b>22<\/b>, 75\u201395 (2021).","DOI":"10.1038\/s41580-020-00314-w"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) He S, Sharpless NE. Senescence in health and disease. <i>Cell<\/i>, <b>169<\/b>, 1000\u20131011 (2017).","DOI":"10.1016\/j.cell.2017.05.015"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Koual M, Tomkiewicz C, Cano-Sancho G, Antignac J, Bats A, Coumoul X. Environmental chemicals, breast cancer progression and drug resistance. <i>Environ. Health<\/i>, <b>19<\/b>, 117 (2020).","DOI":"10.1186\/s12940-020-00670-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Miller ME, Holloway AC, Foster WG. Benzo-[a]-pyrene increases invasion in MDA-MB-231 breast cancer cells <i>via<\/i> increased COX-II expression and prostaglandin E2 (PGE2) output. <i>Clin. Exp. Metastasis<\/i>, <b>22<\/b>, 149\u2013156 (2005).","DOI":"10.1007\/s10585-005-6536-x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Wang TH, Huang KY, Chen CC, Chang YH, Chen HY, Hsueh C, Liu YT, Yang SH, Yang PC, Chen CY. PM2. 5 promotes lung cancer progression through activation of the AhR-TMPRSS2-IL18 pathway. <i>EMBO Mol. Med.<\/i>, <b>15<\/b>, e17014 (2023).","DOI":"10.15252\/emmm.202217014"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Liamin M, Boutet-Robinet E, Jamin EL, Fernier M, Khoury L, Kopp B, Le Ferrec E, Vignard J, Audebert M, Sparfel L. Benzo[a]pyrene-induced DNA damage associated with mutagenesis in primary human activated T lymphocytes. <i>Biochem. Pharmacol.<\/i>, <b>137<\/b>, 113\u2013124 (2017).","DOI":"10.1016\/j.bcp.2017.04.025"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Bukowska B, Mokra K, Micha\u0142owicz J. Benzo[<i>a<\/i>]pyrene\u2014environmental occurrence, human exposure, and mechanisms of toxicity. <i>Int. J. Mol. Sci.<\/i>, <b>23<\/b>, 6348 (2022).","DOI":"10.3390\/ijms23116348"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kudlova N, De Sanctis JB, Hajduch M. Cellular senescence: molecular targets, biomarkers, and senolytic drugs. <i>Int. J. Mol. Sci.<\/i>, <b>23<\/b>, 4168 (2022).","DOI":"10.3390\/ijms23084168"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Sun T, Zhang L, Feng J, Bao L, Wang J, Song Z, Mao Z, Li J, Hu Z. Characterization of cellular senescence in doxorubicin-induced aging mice. <i>Exp. Gerontol.<\/i>, <b>163<\/b>, 111800 (2022).","DOI":"10.1016\/j.exger.2022.111800"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Blagosklonny MV. Cellular senescence: when growth stimulation meets cell cycle arrest. <i>Aging<\/i>, <b>15<\/b>, 905\u2013913 (2023).","DOI":"10.18632\/aging.204543"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Orrantia-Borunda E, Anchondo-Nu\u00f1ez P, Acu\u00f1a-Aguilar LE, G\u00f3mez-Valles FO, Ram\u00edrez-Valdespino CA. Subtypes of Breast Cancer. <i>Breast Cancer<\/i>. (Kiran C. Mayrovitz HN eds.) Exon Publications, pp. 31\u201342 (2022).","DOI":"10.36255\/exon-publications-breast-cancer-subtypes"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Allmann S, Mayer L, Olma J, Kaina B, Hofmann TG, Tomicic MT, Christmann M. Benzo[a]pyrene represses DNA repair through altered E2F1\/E2F4 function marking an early event in DNA damage-induced cellular senescence. <i>Nucleic Acids Res.<\/i>, <b>48<\/b>, 12085\u201312101 (2020).","DOI":"10.1093\/nar\/gkaa965"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Gorgoulis V, Adams PD, Alimonti A, <i>et al<\/i>. Cellular senescence: defining a path forward. <i>Cell<\/i>, <b>179<\/b>, 813\u2013827 (2019).","DOI":"10.1016\/j.cell.2019.10.005"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Dong Z, Luo Y, Yuan Z, Tian Y, Jin T, Xu F. Cellular senescence and SASP in tumor progression and therapeutic opportunities. <i>Mol. Cancer<\/i>, <b>23<\/b>, 181 (2024).","DOI":"10.1186\/s12943-024-02096-7"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Wu S, Cao Z, Lu R, Zhang Z, Sethi G, You Y. Interleukin-6 (IL-6)-associated tumor microenvironment remodelling and cancer immunotherapy. <i>Cytokine Growth Factor Rev.<\/i>, <b>S1359610125000012<\/b> <b>(<\/b>2025).","DOI":"10.1016\/j.cytogfr.2025.01.001"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) R\u00e9b\u00e9 C, Ghiringhelli F. Interleukin-1<i>\u03b2<\/i> and cancer. <i>Cancers<\/i>, <b>12<\/b>, 1791 (2020).","DOI":"10.3390\/cancers12071791"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kang Y, Li H, Liu Y, Li Z. Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors. <i>J. Cancer Res. Clin. Oncol.<\/i>, <b>150<\/b>, 221 (2024).","DOI":"10.1007\/s00432-024-05714-5"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Haferkamp S, Tran SL, Becker TM, Scurr LL, Kefford RF, Rizos H. The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence. <i>Aging<\/i>, <b>1<\/b>, 542\u2013556 (2009).","DOI":"10.18632\/aging.100051"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/10\/48_b25-00309\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T03:38:04Z","timestamp":1760758684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/10\/48_b25-00309\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00309","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"article-number":"b25-00309"}}